AZR · Azora Therapeutics, Inc. (DE) · Executive Compensation
$4.00
+0.29 (+7.82%)
At close · Nov 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“the Company has concluded that there is substantial doubt about its ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$10.50M
Shares
2.63M
Volume · Nov 6
78.19K
Avg daily vol (3M)
52.9K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Cary Claiborne | Chief Executive Officer and Member of the Board of Directors | $890,653 |
| Tony Goodman | Chief Operating Officer | $469,967 |
| Vinay Shah | Chief Financial Officer | $458,855 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Cary Claiborne | Chief Executive Officer and Member of the Board of Directors | $976,339 |
| Tony Goodman | Chief Operating Officer | $376,198 |
| Joseph A. M. Truluck | Former Chief Financial Officer | $328,415 |
| Vinay Shah | Chief Financial Officer | $91,204 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Cary Claiborne | Chief Executive Officer and Member of the Board of Directors | $801,621 |
| Bankole A. Johnson | Former Chief Medical Officer | $435,000 |
| Joseph A. M. Truluck | Former Chief Financial Officer | $389,033 |
| Tony Goodman | Chief Operating Officer | $258,932 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Cary Claiborne | Chief Executive Officer and Member of the Board of Directors | $1,196,988 |
| William B. Stilley | Former Chief Executive Officer, Former Executive Vice President and Former Chief Executive Officer of Purnovate, Inc. | $591,576 |
| Joseph A. M. Truluck | Chief Financial Officer | $510,540 |
| Bankole A. Johnson | Former Chief Medical Officer | $489,422 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| William B. Stilley | Former Chief Executive Officer, Former Executive Vice President and Former Chief Executive Officer of Purnovate, Inc. | $1,227,856 |
| Joseph A. M. Truluck | Chief Financial Officer | $624,524 |
| Cary J. Claiborne | Chief Executive Officer since August 18, 2022; Former Chief Operating Officer and Member of the Board of Directors | $466,763 |
| Cary Claiborne | Chief Executive Officer and Member of the Board of Directors | $466,763 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| William B. Stilley | Former Chief Executive Officer and Member of the board of directors | $1,133,903 |
| Joseph A. M. Truluck | Chief Financial Officer | $451,033 |
| Bankole A. Johnson | Chief Medical Officer | $375,000 |
| Cary J. Claiborne | Chief Executive Officer since August 18, 2022; Former Chief Operating Officer and Member of the Board of Directors | — |
| Cary Claiborne | Chief Executive Officer since August 18, 2022; Former Chief Operating Officer and Member of the Board of Directors | — |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| William B. Stilley | Chief Executive Officer and Member of the board of directors | $2,366,387 |
| Bankole A. Johnson | Chief Medical Officer | $1,109,580 |
| Joseph A. M. Truluck | Chief Operating Officer and Chief Financial Officer | $727,074 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| William B. Stilley | Chief Executive Officer and Member of the Board of Directors | $1,211,656 |
| Joseph A. M. Truluck | Chief Operating Officer and Chief Financial Officer | $308,363 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Julie Saiki, Ph.D. | Chief Strategy Officer | Appointed | 2026-10-28 |
| Vinay Shah | Chief Financial Officer | Terminated | 2026-10-28 |
| Celia Economides | Chief Financial Officer | Appointed | 2026-10-28 |
| Cary J. Claiborne | President and Chief Executive Officer | Terminated | 2026-10-28 |
| Matthew Davidson, Ph.D. | President and Chief Executive Officer | Appointed | 2026-10-28 |
| Robertson H. Gilliland | Class II director | Appointed | 2026-09-18 |
| Cary J. Claiborne | Class II director | Appointed | 2026-09-18 |
| Vinay Shah | Chief Financial Officer | Terminated | 2026-08-13 |
| Matthew Davidson | President and Chief Executive Officer | Appointed | 2026-08-13 |
| Cary Claiborne | President and Chief Executive Officer | Terminated | 2026-08-13 |
| Matt Davidson, PhD | newly appointed director | Appointed | 2026-06-11 |
| Wendy Young, Ph.D. | Board of Directors | Appointed | 2026-06-11 |
| Wendy B. Young | Class III Director | Appointed | 2026-06-11 |
| Matt Davidson | Chief Development Officer | Appointed | 2026-06-11 |
| Matt Davidson | Class I Director | Appointed | 2026-06-11 |
| Tony Goodman | Class I Director | Resigned | 2026-06-11 |
| James W. Newman, Jr. | member of the Board of Directors | Resigned | 2026-01-06 |
| Tony Goodman | Chief Operating Officer | Appointed | 2025-03-21 |
| Joseph Truluck | Chief Financial Officer | Resigned | 2024-11-05 |
| Vinay K. Shah | Chief Financial Officer | Appointed | 2024-11-05 |
| Vinay Shah | Chief Financial Officer | Appointed | 2024-11-05 |
| Joseph Truluck | Chief Financial Officer | Resigned | 2024-11-05 |
| Dr. Bankole A. Johnson | Consultant | Terminated | 2024-04-26 |
| Dr. Bankole A. Johnson | Chief Medical Officer | Terminated | 2024-04-16 |
| Tony Goodman | Chief Operating Officer | Appointed | 2024-01-18 |
Leadership
- Matthew Davidson CEO
- Matthew Davidson, Ph.D. CEO
- William B. Stilley CEO
- Kevin Schuyler Chairman
- Celia Economides CFO
- Vinay K. Shah CFO
- Cary Claiborne COO, Board Member
- Cary J. Claiborne COO, Board Member
- Tony Goodman COO
- Dr. Jack Reich Board Member
- Matt Davidson Board Member
- Matt Davidson, PhD Board Member
- Robertson Gilliland Board Member
- Robertson H. Gilliland Board Member
- Robertson H. Gilliland, MBA Board Member
- Wendy B. Young Board Member
- Wendy Young, Ph.D. Board Member